Publications by authors named "D VAN DEN Bossche"
Unlabelled: The ResistAZM randomized controlled trial found that the receipt of ceftriaxone/azithromycin, compared to ceftriaxone was not associated with an increase in the proportion of oral commensal Neisseria spp. and streptococci with azithromycin resistance 14 days after treatment. We repeated the analyses by measuring the minimum inhibitory concentrations (MICs) of azithromycin and ceftriaxone for individual colonies of commensal Neisseria spp.
View Article and Find Full Text PDFArticle Synopsis
- The PreLeisH study investigated Leishmania markers in HIV-positive individuals at risk of visceral leishmaniasis (VL) in Ethiopia, aiming to predict VL and create a management strategy.
- Over two years, researchers tracked 490 participants, finding that specific Leishmania tests could effectively indicate VL risk levels, with 92.3% classified as low risk.
- The study highlights the importance of identifying high-risk individuals for targeted intervention, emphasizing the need for further research in this area.
: The use of antimicrobials to treat food animals leaves antimicrobial residues in foodstuffs. The World Health Organization (WHO) defines the acceptable daily intakes (ADIs) of these residues as the dose of these antimicrobials that is safe for an average human to consume on a daily basis. We hypothesized that the lowest dose of ciprofloxacin classified as safe by the WHO could select for ciprofloxacin-resistant strains of in a model.
View Article and Find Full Text PDFArticle Synopsis
- Scientists studied how to fight bacteria that are resistant to a medicine called ceftriaxone.
- They tested different drugs to see if they could work together with ceftriaxone to stop the bacteria from becoming resistant.
- The results showed that two specific drugs, zoliflodacin and pristinamycin, could help reduce the chances of ceftriaxone resistance spreading.